ChromoGenics publishes prospectus
ChromoGenics AB (“ChromoGenics” or “the Company”) today publishes a prospectus which has been approved and registered with the Swedish Financial Supervisory Authority in connection with the forthcoming new share issue. The prospectus is available on ChromoGenics’ website (www.chromogenics.com), Erik Penser Bank's website (www.penser.se) and Finansinspektionen's website (www.fi.se).Prospectus The prospectus that ChromoGenics has prepared in connection with the forthcoming new share issue has today been approved and registered by the Swedish Financial Supervisory Authority. The prospectus,